DGHO Annual Conference 2024
Meet BIOTYPE at the DGHO Annual Conference 2024 in Basel!
Let’s connect at this year's DGHO annual conference, taking place from 11 to 14 October 2024 in Basel, Switzerland, and explore how our precision oncology products and solutions can meet your in-house molecular testing needs.
Effective genetic testing for AML is essential for patient stratification, prognosis, and optimal treatment outcomes. Our Mentype® AMLplexQS PCR Amplification Kit and the upcoming MODAPLEX AML Panel offer cutting-edge tools for detecting clinically relevant gene fusions or mutations, leveraging advanced technologies to support screening in leukemic samples.
In addition, our PCR-based solutions enable comprehensive molecular profiling for various cancer entities, utilizing nucleic acids extracted from sources such as FFPE or blood. Discover our latest innovations for rapid and precise analysis of biomarkers like ESR1, POLE, and FGFR2/3, ensuring alignment with current clinical guidelines and empowering accurate patient treatment strategies
Are you attending DGHO?
Contact our experts Marie Helbig and Dr. Doğan Doruk Demircioğlu to schedule a meeting and learn how our diagnostics portfolio can enhance your molecular profiling capabilities!
We are looking forward to many inspiring talks and discussions!
